P Meijnen

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. ncbi [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer]
    Ph Meijnen
    Het Nederlands Kanker Instituut Antoni van Leeuwenhoek Ziekenhuis, Plesmanlaan 121, 1066 CX Amsterdam
    Ned Tijdschr Geneeskd 148:2428-32. 2004
  2. ncbi Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast
    Ph Meijnen
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 31:833-9. 2005
  3. ncbi Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast
    Philip Meijnen
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Ann Surg Oncol 15:235-43. 2008
  4. ncbi Immunohistochemical categorisation of ductal carcinoma in situ of the breast
    P Meijnen
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    Br J Cancer 98:137-42. 2008
  5. ncbi Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy
    P Meijnen
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Br J Surg 94:952-6. 2007
  6. ncbi Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group
    Emiel J T Rutgers
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Breast Cancer Res 6:165-9. 2004
  7. ncbi Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and
    Nina Bijker
    Department of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 24:3381-7. 2006
  8. ncbi Multifocal ductal carcinoma in situ of the breast: a contraindication for breast-conserving treatment?
    Philip Meijnen
    J Clin Oncol 25:5548-9. 2007

Detail Information

Publications8

  1. ncbi [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer]
    Ph Meijnen
    Het Nederlands Kanker Instituut Antoni van Leeuwenhoek Ziekenhuis, Plesmanlaan 121, 1066 CX Amsterdam
    Ned Tijdschr Geneeskd 148:2428-32. 2004
    ..2% on average). Hence, the benefit of detailed pathologic examination with step sectioning and the application of immunohistochemical staining may be doubted...
  2. ncbi Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast
    Ph Meijnen
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 31:833-9. 2005
    ....
  3. ncbi Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast
    Philip Meijnen
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Ann Surg Oncol 15:235-43. 2008
    ..The effect of treatment of patients diagnosed with ductal carcinoma in situ (DCIS) of the breast was evaluated, and factors associated with local recurrence were assessed...
  4. ncbi Immunohistochemical categorisation of ductal carcinoma in situ of the breast
    P Meijnen
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    Br J Cancer 98:137-42. 2008
    ..Morphologically, intermediately differentiated DCIS seems to have more biological similarities with well-differentiated lesions as compared to poorly differentiated lesions...
  5. ncbi Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy
    P Meijnen
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Br J Surg 94:952-6. 2007
    ..The data were used to select criteria for patients in whom sentinel node (SN) biopsy might be indicated...
  6. ncbi Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group
    Emiel J T Rutgers
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Breast Cancer Res 6:165-9. 2004
    ....
  7. ncbi Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and
    Nina Bijker
    Department of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 24:3381-7. 2006
    ..We analyzed the efficacy of RT with 10 years follow-up on both the overall risk of local recurrence (LR) and related to clinical, histologic, and treatment factors...
  8. ncbi Multifocal ductal carcinoma in situ of the breast: a contraindication for breast-conserving treatment?
    Philip Meijnen
    J Clin Oncol 25:5548-9. 2007